ga naar hoofdinhoud
Vademecum systeemtherapie Neuro-oncologie Literatuur en richtlijnen
Voorlezen

Literatuur

  1. Stupp R et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352:987-96
  2. Perry JR et al. Short-course radiation plus temozolomide in elderly patients with glioblastoma. N Engl J Med 2017; 376:1027-1037
  3. Wick W et al. Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma. J Clin Oncol 2010; 28:1168-74
  4. Van den Bent MJ et al. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol 2013; 31:344-50
  5. Van den Bent MJ et al. Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study. Lancet 2017; 390:1645-1653
  6. Van den Bent MJ et al. Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of 
    a randomised, open-label, phase 3 trial. Lancet Oncol 2026; 27:45-46

Commissie BOM adviezen

Ga naar de commissie BOM adviezen over glioom.

Richtlijnen

Ga naar de richtlijn Gliomen in de FMS richtlijnen­database.

Ga naar de regeling bijzondere neurochirurgie op de website Overheid.nl.